Enovis Corporation (ENOV)
Company Description
Enovis Corporation operates as a medical technology company worldwide.
It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries.
It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger.
Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand.
The company was formerly known as Colfax Corporation.
Enovis Corporation is headquartered in Wilmington, Delaware.

Country | United States |
IPO Date | May 8, 2008 |
Industry | Industrial - Machinery |
Sector | Industrials |
Employees | 7,367 |
CEO | Matthew L. Trerotola |
Contact Details
Address: 2711 Centerville Road Wilmington, Delaware United States | |
Website | https://www.enovis.com |
Stock Details
Ticker Symbol | ENOV |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001420800 |
CUSIP Number | 194014502 |
ISIN Number | US1940145022 |
Employer ID | 54-1887631 |
SIC Code | 3842 |
Key Executives
Name | Position |
---|---|
Matthew L. Trerotola | Chief Executive Officer & Chairman |
Phillip Benjamin Berry | Senior Vice President & Chief Financial Officer |
Brian P. Hanigan | Secretary |
Davide Visentin | President of Enovis International Surgical |
Katie Sweet | Vice President of Corporate Communication |
Louie Vogt | Group President of Reconstructive |
Terry D. Ross | Group President Prevention & Recovery |
Tim Czartoski | President of U.S. Surgical and Global Product & Enabling Technologies |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 11, 2025 | 4 | Filing |
Apr 11, 2025 | DEFA14A | Filing |
Apr 11, 2025 | DEF 14A | Filing |
Apr 02, 2025 | 8-K | Current Report |
Apr 01, 2025 | 4 | Filing |
Mar 14, 2025 | 8-K | Current Report |
Mar 11, 2025 | 4 | Filing |
Mar 11, 2025 | 4 | Filing |
Mar 11, 2025 | 4 | Filing |
Mar 11, 2025 | 4 | Filing |